Eclipse Topical Analgesic FA: Package Insert and Label Information

ECLIPSE TOPICAL ANALGESIC FA- benzocaine cream
Sambria Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

​Active Ingredients

Benzocaine 20.0% w/w

​Purpose

External Analgesic

​Uses

For temporary relief of pain and itching due to minor skin irritation.

​Warnings

​For external use only

Avoid contact with eyes

​Stop use and ask doctor if

• Condition worsens, or if symptoms persist for more then 7 days or clear up and occur again within a few days. Discontinue use.

​Keep out of reach of children

• If product is swallowed, get medical help or contact a Poison Control Center right away.

​Directions

For adults and children two-years or older: Apply to affected area not more then 3 or 4 times daily. Children under 2 years of age: consult a physician.

​Inactive Ingredients

Aqua (Deionized Water), Arnica Montana Flower Extract, C13-14 Isoparaffin, Caprylic/Capric Triglyceride, Cetearetj-25, Chondroitin Sulfate, Diethylhexyl Sodium Sulfosuccinate, Emu Oil, Ethoxydiglycol, Ethylhexylglycerin, Glucosamine Sulfate, Glycerin, Isopropyl Palmitate, Laureth-7, Melaleuca alternifolia (Tea Tree) Leaf Oil, Methylfulfonylmenthane (MSM), Phenoxyethanol, Polyacrylamide, Polysorbate-20, Safflower Oil, Stearic Acid, Triethanolamine

​Other Information

Protect this product from excessive heat or direct sun.

​Questions or Comments?

FDA Registered: NDC No. 54723-668-03

800-759-6876

packet
(click image for full-size original)

ECLIPSE TOPICAL ANALGESIC FA
benzocaine cream
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:54723-668
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BENZOCAINE (BENZOCAINE) BENZOCAINE 20 mg in 100 mg
Inactive Ingredients
Ingredient Name Strength
water
ARNICA MONTANA FLOWER
C13-14 ISOPARAFFIN
MEDIUM-CHAIN TRIGLYCERIDES
CETEARETH-25
CHONDROITIN SULFATE SODIUM (BOVINE)
DOCUSATE SODIUM
EMU OIL
DIETHYLENE GLYCOL MONOETHYL ETHER
ETHYLHEXYLGLYCERIN
GLUCOSAMINE SULFATE
GLYCERIN
ISOPROPYL PALMITATE
LAURETH-7
MELALEUCA ALTERNIFOLIA LEAF
DIMETHYL SULFONE
PHENOXYETHANOL
POLYACRYLAMIDE (10000 MW)
POLYSORBATE 20
SAFFLOWER OIL
STEARIC ACID
TROLAMINE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54723-668-03 3000 mg in 1 PACKET None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part348 02/01/2016
Labeler — Sambria Pharmaceuticals, Inc. (078676259)
Establishment
Name Address ID/FEI Operations
A.I.G. Technologies, Inc. 171837367 manufacture (54723-668)
Establishment
Name Address ID/FEI Operations
JP Packaging LLC 151369456 repack (54723-668)

Revised: 08/2018 Sambria Pharmaceuticals, Inc.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.